arrow
G

G. Aaron Hobbs

Medical University of South Carolina
H指数:21
被引数:5,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Secreted frizzled-related protein 2 monoclonal antibody-mediated IFN-ϒ reprograms tumor-associated macrophages to suppress triple negative breast cancer

分泌性卷曲相关蛋白2单克隆抗体介导的IFN-ϒ重编程肿瘤相关巨噬细胞以抑制三阴性乳腺癌

2025-12-050
OAAI
HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer
2024-05-282
OAAI
Functional and biological heterogeneity of KRASQ61 mutations

KRASQ61突变的功能和生物学异质性

2022-08-0915
OA
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
2022-07-0826
OAAI
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

同时抑制ERK和法尼基转移酶抑制HRAS突变型头颈部鳞状细胞癌的生长

2022-02-2814
OA
Targeting p130Cas-and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

靶向p130Cas-and微管依赖的MYC调节使胰腺癌对ERK MAPK抑制敏感

2021-06-0118
OAAI
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer (vol 25, pg 628, 2019)

ERK和自噬抑制的组合作为胰腺癌的治疗方法 (第25卷,628页,2019)

2020-06-0117
OAAI
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

非典型KRASG12R突变体在胰腺癌的PI3K信号传导和巨胞饮作用中受损

2020-01-09139
OAAI
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

ERK联合自噬抑制治疗胰腺癌的研究进展

2019-03-04526
OAAI
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies

评估同工型和突变特异性RAS抗体的选择性和敏感性

2017-09-2652
OAAI